Aurix

About Nuo Therapeutics

Nuo Therapeutics is a U.S.-based biomedical company founded in 2007, operating in the regenerative medicine and wound care sectors. It has reached the commercial stage with its lead product, Aurix, a personalized hematogel therapy derived from a patient's blood. The company's strategy centers on leveraging a patient's innate biology to improve healing outcomes while aiming to demonstrate value within the health economic system. Its operations are headquartered in Gaithersburg, Maryland.

Therapeutic Areas